In the News

JDRF Applauds the Government of Nova Scotia’s Commitment in Funding an Insulin Pump Program for Nova Scotians Living with Type 1 Diabetes

TORONTO (April 4, 2013) – JDRF applauds the Government of Nova Scotia’s commitment in the 2013 Provincial Budget to fund an insulin pump program for eligible Nova Scotians living with type 1 diabetes (T1D).  

Emerging Technologies in Diabetes Research

The JDRF Emerging Technologies E-Newsletter No. 9

JDRF Launches Online Service to Connect People with Diabetes with Clinical Trial Information

NEW YORK, NY, July 29, 2009 - The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research, announced today that it has launched an on-line service for people with type 1 diabetes and their ...

JDRF, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

New York, NY, August 5, 2009 -- JDRF said today that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform.  The four-year program is one of the largest and ...

Researchers Show Non-Insulin-Producing Alpha Cells in the Pancreas Can Be Converted To Insulin-Producing Beta Cells

New York, NY, August 6, 2009 -- In findings that add to the prospects of regenerating insulin-producing cells in people with type 1 diabetes, researchers in Europe -- co-funded by the Juvenile Diabetes Research Foundation -- have shown that insulin-producing beta cells can be derived from non-insulin-producing ...

Medtronic Recalls Certain Lots of Paradigm Quick-Set Infusion Sets

OTTAWA - Health Canada is advising Canadians that the company Medtronic has initiated a recall of its Paradigm Quick-set infusion sets with lot numbers beginning with "8" ("Lot 8"). A small percentage of the affected infusion sets may work improperly and may deliver too much or too ...

Two JDRF-Funded Studies Show Regular CGM Use Increases Diabetes Control for All Age Groups and Enables Patients to Maintain Good Control Long Term

NEW YORK, September 8, 2009 -- The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors -- six days per week or more -- rather ...

New "Hannah Montana" Episode to Spotlight Type 1 Diabetes

New York, NY, September 17, 2009 -- A new episode of "Hannah Montana" that deals with type 1 diabetes will premiere on the Disney Channel on Sunday, September 20 at 7:30 p.m. ET/PT.  The show's producers consulted with the Juvenile Diabetes Research Foundation (JDRF), the leader in setting ...

Stem cell research guidelines to be proposed at U.S. summit

A charter devised by Canadians outlining the ethical principles that should guide international stem cell research is being presented Tuesday at the World Stem Cell Summit in Baltimore.

JDRF Social Networking Site Surpasses 7,000 Active Members and Attracts New Constituency

New York, NY, September 25, 2009 -- More than 7,000 people with type 1 diabetes are sharing their hopes, fears, trials, tribulations, problems, concerns, and triumphs in dealing with their disease on a new social network site developed by the Juvenile Diabetes Research Foundation.

Lets turn type one into type none